Evidence map›Paper›PMID 21971406›Full record

Trial reportJournal of Alzheimer's disease : JAD2012

High-intensity physical activity modulates diet effects on cerebrospinal amyloid-β levels in normal aging and mild cognitive impairment.

Laura D Baker, Jennifer L Bayer-Carter, Jeannine Skinner, Thomas J Montine, Brenna A Cholerton, Maureen Callaghan, James B Leverenz, Brooke K Walter, Elaine Tsai, Nadia Postupna and 2 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of Alzheimer's disease : JAD, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Dietary patterns and β-amyloid deposition in aging Australian women.Alzheimer's & dementia (New York, N. Y.) · 2018
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Laura D BakerGeriatric Research, Education, and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA. ldbaker@uw.edu
Jennifer L Bayer-Carter
Jeannine Skinner
Thomas J Montine
Brenna A Cholerton
Maureen Callaghan
James B Leverenz
Brooke K Walter
Elaine Tsai
Nadia Postupna
Johanna Lampe
Suzanne Craft
Geriatric Research Education and Clinical Center · USUniversity of Washington · USVA Puget Sound Health Care System · USFred Hutch Cancer Center · USUniversity of Puget Sound · US

Funding

THERAPEUTIC EFFECTS OF INTRA-NASAL INSULIN DETEMIRP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI JAYADEY, SUMAN · 1985 to 2019
$57.2M
Glucose Regulation and Memory in Alzheimer's DiseaseR37AG010880 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CRAFT, SUZANNE · 2005 to 2014
$5.2M
NEUROBEHAVIOR, NEUROENDOCRINOLOGY, AND GENETICS OF ADT32AG000258 · NIA · UNIVERSITY OF WASHINGTON · PI MONTINE, THOMAS J · 1999 to 2013
$4.7M
GLUCOSE REGULATION AND MEMORY IN ALZHEIMERS DISEASER01AG010880 · NIA · WASHINGTON UNIVERSITY · PI CRAFT, SUZANNE · 1992 to 2004
$1.0M
NIA NIH HHS 5T32 AG000258NIA NIH HHS P50 AG005136NIA NIH HHS P50 AG05136NIA NIH HHS R01 AG010880NIA NIH HHS R37 AG010880NIA NIH HHS R37 AG-10880NIA NIH HHS T32 AG000258
6 · The paper itself

Abstract

We previously showed that amyloid-β 1-42 (Aβ(42)) levels in cerebrospinal fluid (CSF) were markedly altered in response to a 4-week dietary intervention in normal aging and mild cognitive impairment (MCI). Here, we re-examined the data to assess whether diet-induced effects on CSF Aβ(42) were modulated by high intensity physical activity (hi-PA). Normal older adults (n = 18, mean age = 68.6 ± 7.4 y) and adults with amnestic MCI (n = 23, mean age = 68.0 ± 6.5 y) received a low saturated fat/low glycemic index (LOW) diet or a high saturated fat/high glycemic index (HIGH) diet, and CSF levels of Aβ(42), tau, and IL-8 were measured at baseline and week 4. Pre-study activity levels were assessed using a 7-d questionnaire, and weekly duration of hi-PA was quantified. At baseline, increased hi-PA in normals predicted lower CSF levels of tau (r = -0.54, p = 0.020) and IL-8 (r = -0.70, p = 0.025). Diet-induced effects on CSF Aβ(42) during the intervention study were modulated by hi-PA, and the nature of this effect differed for normals and MCI (ANOVA, p = 0.039). That is, for normal adults, increased hi-PA attenuated the effects of the HIGH diet on CSF Aβ(42) whereas in MCI, increased hi-PA potentiated the effects of the LOW diet. Our results suggest that normal adults who engage in hi-PA are less vulnerable to the pathological effects of an unhealthy diet, while in MCI, the benefit of a healthy diet on Aβ modulation is greatest when paired with hi-PA. Exercise may thus interact with diet to alter pathological processes that ultimately modify risk of Alzheimer's disease.

Indexed as

Diet, Fat-RestrictedDiet, High-FatAgedAgingAmyloid beta-PeptidesBiomarkersCognitive DysfunctionDietFemaleFollow-Up StudiesHumansMaleMiddle AgedMotor ActivityPeptide FragmentsRisk Reduction BehaviorAmyloid beta-Peptidesamyloid beta-protein (1-42)BiomarkersPeptide Fragments

Identifiers

PMID21971406
PMCPMC3280092
OpenAlexW2113571762

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.